Free Trial

Orchestra BioMed (OBIO) Institutional Ownership

Orchestra BioMed logo
$2.43 -0.12 (-4.71%)
Closing price 04:00 PM Eastern
Extended Trading
$2.43 0.00 (0.00%)
As of 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)

Current
Institutional Ownership
Percentage
53.20%
Number of
Institutional Buyers
(last 12 months)
28
Total
Institutional Inflows
(last 12 months)
$16.92M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$1.41M
Get OBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

OBIO Institutional Buying and Selling by Quarter

Orchestra BioMed Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Tower Research Capital LLC TRC 27,922$75K0.0%+1,137.7%0.072%
8/15/2025 Bridgeway Capital Management LLC25,000$67K0.0%N/A0.065%
8/15/2025 Bank of America Corp DE21,577$58K0.0%+35.7%0.056%
8/14/2025 Jane Street Group LLC18,513$50K0.0%N/A0.048%
8/14/2025 The Manufacturers Life Insurance Company 32,518$87K0.0%-22.5%0.084%
8/14/2025 NewEdge Advisors LLC44,083$118K0.0%N/A0.114%
8/13/2025 Marshall Wace LLP49,465$133K0.0%N/A0.128%
8/12/2025 XTX Topco Ltd16,817$45K0.0%N/A0.044%
8/12/2025 Catalyst Funds Management Pty Ltd11,400$31K0.0%N/A0.030%
8/11/2025 Knott David M Jr100,000$268K0.1%N/A0.259%
8/8/2025 Creative Planning15,000$40K0.0%N/A0.039%
8/8/2025 Geode Capital Management LLC302,082$810K0.0%-49.3%0.782%
8/1/2025 Y Intercept Hong Kong Ltd45,447$122K0.0%N/A0.119%
7/24/2025 IFP Advisors Inc85,358$229K0.0%-47.3%0.223%
6/27/2025 Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127%
5/16/2025 Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127%
5/13/2025 HighTower Advisors LLC61,000$261K0.0%-10.9%0.159%
5/12/2025 Nuveen LLC41,729$179K0.0%N/A0.109%
5/9/2025 Deutsche Bank AG20,219$87K0.0%+67.3%0.053%
5/5/2025 IFP Advisors Inc161,921$693K0.0%+106.4%0.423%
2/17/2025 Millennium Management LLC21,513$86K0.0%N/A0.057%
2/17/2025 Citadel Advisors LLC12,279$49K0.0%-39.0%0.032%
2/17/2025 Bank of America Corp DE23,780$95K0.0%+42.0%0.063%
2/14/2025 Boxer Capital Management LLC238,193$953K0.1%N/A0.627%
2/14/2025 Northern Trust Corp236,761$947K0.0%+2.5%0.623%
2/14/2025 The Manufacturers Life Insurance Company37,009$148K0.0%+11.1%0.097%
2/14/2025 Price T Rowe Associates Inc. MD487,170$1.95M0.0%-5.0%1.282%
2/13/2025 Barclays PLC37,786$152K0.0%+18.9%0.099%
2/13/2025 Wells Fargo & Company MN13,156$53K0.0%+43.6%0.035%
2/12/2025 Geode Capital Management LLC572,441$2.29M0.0%+0.9%1.506%
2/12/2025 JPMorgan Chase & Co.49,405$198K0.0%+354.5%0.130%
2/7/2025 HighTower Advisors LLC68,500$274K0.0%+34.3%0.180%
1/17/2025 SG Americas Securities LLC12,785$51K0.0%+26.0%0.034%
11/21/2024 SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032%
11/19/2024 Barclays PLC31,785$163K0.0%+281.3%0.084%
11/16/2024 Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492%
11/15/2024 Barclays PLC31,785$163K0.0%+281.3%0.084%
11/15/2024 Jane Street Group LLC19,070$98K0.0%-19.8%0.050%
11/15/2024 State Street Corp429,613$2.21M0.0%+12.4%1.130%
11/15/2024 RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587%
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel

Watch the National Emergency broadcast here
11/13/2024 The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088%
11/12/2024 Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574%
11/1/2024 ABLE Financial Group LLC13,402$69K0.0%N/A0.035%
10/3/2024 SG Americas Securities LLC10,143$52K0.0%N/A0.028%
8/16/2024 SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056%
8/15/2024 The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118%
8/1/2024 Rhumbline Advisers26,439$215K0.0%+192.7%0.074%
7/26/2024 Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197%
5/15/2024 Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596%
5/11/2024 Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062%
2/1/2024 New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010%
10/27/2023 Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014%
10/27/2023 TD Asset Management Inc92,678$808K0.0%+100.0%0.259%
10/24/2023 Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113%
10/18/2023 UMB Bank n.a.3,160$28K0.0%N/A0.009%
10/13/2023 Arkadios Wealth Advisors51,595$450K0.0%N/A0.144%
8/24/2023 Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744%
8/11/2023 Atika Capital Management LLC64,651$453K0.0%N/A0.181%
5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230%
5/15/2023 RTW Investments LP5,118,507$100.17M2.1%N/A45.652%
4/18/2023 IFP Advisors Inc2,980$34K0.0%N/A0.027%
(Data available from 1/1/2016 forward)

OBIO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OBIO shares?

During the previous two years, 41 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), State Street Corp ($2.21M), Price T Rowe Associates Inc. MD ($1.95M), Charles Schwab Investment Management Inc. ($1.12M), Boxer Capital Management LLC ($953K), and Northern Trust Corp ($947K).Learn more on Orchestra BioMed's institutional investors.

What percentage of Orchestra BioMed's stock is owned by institutional investors?

53.20% of Orchestra BioMed's stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings.

Which institutional investors have been buying Orchestra BioMed's stock?

Of the 36 institutional investors that purchased Orchestra BioMed's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($2.59M), Boxer Capital Management LLC ($238.19K), Knott David M Jr ($100K), IFP Advisors Inc ($83.48K), Bank of New York Mellon Corp ($65.25K), Barclays PLC ($52.90K), and Arkadios Wealth Advisors ($51.60K).

How much institutional buying is happening at Orchestra BioMed?

Institutional investors have bought a total of 3,562,853 shares in the last 24 months. This purchase volume represents approximately $16.92M in transactions.

Which of Orchestra BioMed's major shareholders have been selling company stock?

Of the 9 institutional investors that sold Orchestra BioMed's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Geode Capital Management LLC ($293.35K), IFP Advisors Inc ($76.56K), Goldman Sachs Group Inc. ($26.82K), Price T Rowe Associates Inc. MD ($25.49K), The Manufacturers Life Insurance Company ($18.24K), Citadel Advisors LLC ($7.84K), and SkyView Investment Advisors LLC ($7.72K).

How much institutional selling is happening at Orchestra BioMed?

Institutional investors have sold a total of 468,229 shares in the last 24 months. This volume of shares sold represents approximately $1.41M in transactions.



This page (NASDAQ:OBIO) was last updated on 8/20/2025 by MarketBeat.com Staff
From Our Partners